How many clinical trials are tracked of intravenous immunoglobulin (IVIG)?

5 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

intravenous immunoglobulin (IVIG)

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of intravenous immunoglobulin (IVIG)

5 trials tracked of intravenous immunoglobulin (IVIG): 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 80 citations.

5Trials tracked

1Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 1 Phase 2 3 Phase 1 1

Phase 3 A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia Completed · 80 cited
Phase 2 Stem Cell Transplant for Immunologic or Histiocytic Disorders Completed
Phase 2 Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins Completed
Phase 2 Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia Completed
Phase 1 Infliximab (Remicade) for Patients With Acute Kawasaki Disease Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.